AKNETIDE® - Dermatologist Tested Anti-Acne Ingredient
Introducing AKNETIDE®
A Natural Antimicrobial Cyclopeptide
AKNETIDE® is a natural cyclopeptide that mimics host defense mechanisms, specifically targeting Cutibacterium acnes while regulating sebum oversecretion, alleviating inflammation, and expediting skin lesion repair — very gentle even to sensitive skin.
Key Insights from a global market Research*
Where to Start
About us
Pioneers in Natural Anti-Acne Solutions
Mission
At Dermatide Singapore, our mission is to invent & produce & deliver novel & efficacious & stable bioactive ingredients to empower individuals to achieve better beauty with confidence through science-backed and evidence-endorsed solutions.
Values
We are guided by a firm commitment to sustainability and nature, from natural ingredient discovery to the next-generation skincare technology development.
Our Team
Our Team are made up of industry experts, scientists, and thought leaders who guide us in shaping innovative, effective, and sustainable skincare solutions. Their insights and expertise help drive our commitment to excellence in every product we create.
Dr. Wang Jinfang
Sr. Scientific Advisor
A Ph.D in Analytical Chemistry from the Chinese Academy of Sciences and a double PhD in Organic Chemistry from the University of Strathclyde, UK, with 6 years of overseas study and postdoctoral experience. A Fellow of the Royal Society of Chemistry (FRSC).
He used to work at Unilever China for 20 years since 2005, ever positioned as Principal Research Scientist and R&D Personal Care Director.
Robin Yao
President
MBA and MSc degrees. 10 years’ experiences in venture capital investment focusing on global biotech innovations, and 5 years’ experiences in corporate investment also focused on global biotech business. Co-founder of Planet Bioscience Pte Ltd in Singapore.
Dr. Lu Yanxia
Technical Director
French National Laboratory, Master’s and PhD.
Over 10 years’ experience in basic research in the daily cosmetics industry; previously worked at Unilever’s R&D Center as a senior researcher in the basic research team, at Chando Group as a senior manager, building and leading a clinical application basic research team and worked at Yige Group (Florasis) as a director, building and leading an applied basic research team.
OUR FOOTPRINTS
Dermatide Biotech Showcases AKNETIDE at In-Cosmetics Global 2026, Secures Strong European Partnerships
PCHi 2026
🌟 What an extraordinary debut at PCHi 2026 in Hangzhou, China!
Dermatide Biotec, together with our trusted China representative, had an incredible three days last week connecting with the global beauty and personal care community. Hundreds of visitors from across the US, EU, Japan, South Korea, Thailand, Vietnam and beyond stopped by our booth — and the conversations were everything we could have hoped for: curious, technical, and genuinely energized.
The spotlight? AKNETIDE®— the world’s NOVEL antimicrobial cyclopeptide derived from Bacillus fermentation, purpose-built for cosmetic acne care. The interest from formulators and ingredient professionals around our 4-in-1 multi-mechanism active was deeply encouraging. And we had more than a few exciting conversations about what’s coming next in our R&D pipeline — bioactive peptides with broader personal care applications that we can’t wait to share in the months ahead.
To every visitor, conversation partner, and connector at PCHi — thank you. This is exactly why we show up. Here’s to a thriving Year of the Horse 🐎 and to building something remarkable together in 2026!
Look forward to meeting friends at In-Cosmetic Global in Paris in April.
In-Cosmetics Global 2025
We were delighted to attend in-cosmetics Global 2025 in Amsterdam, the Netherlands where we first ever introduced our innovative cosmetic ingredient — AKNETIDE®. As a world first-in-class Anti-acne Antimicrobial Cyclopeptide designed for efficient acne care, AKNETIDE® attracted strong interest from industry professionals, distributors & formulators, and brand developers.
In-Cosmetics Asia 2025
We had the pleasure of attending the In-Cosmetic Asia 2025 Expo in-cosmetics Asia in Bangkok. Our product, AKNETIDE®, garnered significant attention from global key distributors’ innovation leaders due to its solid and comprehensive technical dataset to tell a clear and convincing fact-based story how this first-in-class AKNETIDE® is able to be incredibly efficaciously against acne care but still so gentle to skin types, including in-vitro efficacy,clinical studies, in-vitro mechanism study including gene regulation analysis and in-vitro safety study.
Paris, France – April 2026 – Following a highly successful exhibition at In-Cosmetics Global 2026 in Paris, we are thrilled to announce a significant milestone in our international expansion. Our proprietary antimicrobial cyclopeptide, AKNETIDE, captured substantial attention from leading European distribution partners, validating our commitment to deep tech, science-backed personal care innovations.
Throughout the event, our team had the opportunity to present the robust scientific dataset behind AKNETIDE. The strong reception from industry leaders was driven by our comprehensive, placebo-controlled clinical study results, which clearly demonstrate the peptide’s targeted efficacy and safety profile in anti-acne applications.
As a biotechnology innovator focused on next-generation bioactive molecules, we understand that modern personal care formulators demand not just novel ingredients, but irrefutable clinical evidence. The overwhelming interest from influential European distributors confirms that AKNETIDE’s rigorous R&D foundation—stemming from our specialized focus on high-performance molecules—is exactly what the global market is seeking.
We are currently advancing discussions with several key European partners to establish a strong distribution network across the EU. These strategic alliances will be instrumental in bringing our advanced biomolecular solutions to a wider audience, empowering formulators to create highly effective, scientifically validated skincare products.
Stay tuned for more updates as we finalize these partnerships and continue to push the boundaries of biotechnology in personal care.
He used to work at Unilever China for 20 years since 2005, ever positioned as Principal Research Scientist and R&D Personal Care Director.
In-Cosmetics Global 2025
We were delighted to attend in-cosmetics Global 2025 in Amsterdam, the Netherlands where we first ever introduced our innovative cosmetic ingredient — AKNETIDE®. As a world first-in-class Anti-acne Antimicrobial Cyclopeptide designed for efficient acne care, AKNETIDE® attracted strong interest from industry professionals, distributors & formulators, and brand developers.
In-Cosmetics Global 2025
We had the pleasure of attending the In-Cosmetic Asia 2025 Expo in-cosmetics Asia in Bangkok. Our product, AKNETIDE®, garnered significant attention from global key distributors’ innovation leaders due to its solid and comprehensive technical dataset to tell a clear and convincing fact-based story how this first-in-class AKNETIDE® is able to be incredibly efficaciously against acne care but still so gentle to skin types, including in-vitro efficacy,clinical studies, in-vitro mechanism study including gene regulation analysis and in-vitro safety study.
Frequently Asked Questions
AKNETIDE® is a first-in-class natural antimicrobial cyclopeptide developed for cosmetic acne care. It targets all four root causes of acne vulgaris — Cutibacterium acnes inhibition, sebum regulation, inflammation reduction, and skin repair — in a single ingredient. It is COSMOS-approved, Halal certified, and dermatologist tested.
AKNETIDE® is designed for cosmetic and personal care manufacturers (B2B) seeking a clinically validated, multi-mechanism anti-acne active that is safe for sensitive skin and compliant with clean beauty standards. It is suitable for formulation into serums, moisturisers, cleansers, toners, and targeted spot treatments.
AKNETIDE® is the first cosmetic-grade antimicrobial cyclopeptide for acne. Unlike conventional actives (salicylic acid, benzoyl peroxide, niacinamide) which address one or two acne pathways, AKNETIDE® simultaneously addresses all four: bacterial inhibition, sebum control, inflammation, and repair. In a 7-day clinical study, it reduced blackheads by 88.7% and papules by 51.0%.
Yes. Dermatide is headquartered in Singapore and supplies AKNETIDE® to cosmetic manufacturers globally. The ingredient has been presented at In-Cosmetics Global (Amsterdam), In-Cosmetics Asia (Bangkok), and PCHi (Hangzhou). For samples and collaboration enquiries, contact info@dermatide.net.